Documentation

2026 / 2024  

- Open-label treatment extension of ruxolitinib ncream in vitiligo...

- Prolonged ruxolitinib cream treatment for vitiligo among patients...

- The role of JAK3 and TEC family kinases in vitiligo pathogenesis

- Exposome Risk Factors for Vitiligo: A Systematic Evidence Review

- Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications.

- Vitiligo - nature reviews disease primers

- Three-dimensional imaging for facial vitiligo: Results from a...

- Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications

- Long‑Term Integrated Safety Summary of Ruxolitinib Cream...

- Regulatory T Cell Dysregulation in Vitiligo: A Meta-Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives.

- Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo.

- Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study.

- Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.

- Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks.

- Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies

- Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo

2023 / 2021  

- Vitiligo : prise en charge et perspectives thérapeutiques

- Nouvelle étude dans le traitement du vitiligo ! Critères d'inclusion

- Existe-t-il une fenêtre d'oportunité pour le traitement ?

- Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

- Vitiligo: 30 years to put together the puzzle pieces and to give rise to a new era of therapeutic options.

- Review Male genital vitiligo

- Increased Activation of Innate Immunity and Pro-Apoptotic CXCR3Bin Normal-Appearing Skin on the Lesional Site of Patients with Segmental Vitiligo

- Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis

- Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo

- Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective

- Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin...

2020 / 2016  

- First step in a new era for treatment of patients with vitiligo

- Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

- Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy

- Apremilast in combination to narrowband UVB in the treatment of vitiligo

- Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo

- Pigment Cell & Melanoma Research. Micro holes for delivering melanocytes into the skin

- Comparison of microneedling and full surface erbium laser dermabrasion...

- Atorvastatin in Combination With Narrowband UV-B in Adult Patients With Active Vitiligo

- Normal skin pigmentation and its regeneration

- Vitiligo Perspectives and pipeline

- Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference

- Study of the comparative expression of CXCL9, CXCL10 and IFN in vitiligo and alopecia areata patients

- Medical and maintenance treatments for Vitiligo

2015 / 2010  

- Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway

- Indications and Limitations of Afamelanotide Indications and Limitations of Afamelanotide for Treating Vitiligo

- Maintenance Therapy of Adult Vitiligo with 0.1% Maintenance Therapy of Adult Vitiligo with 0.1% Tacrolimus Ointment

- Hypochromic vitiligo: delineation of a new entity

- Localized depigmentation on genital melanosis BJD

- Laser-assisted depigmentation for resistant vitiligo a retrospective case series with long-term follow-up

- Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?

- Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B

- 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study

2009 / 2001  

- Nodular melanomas associated with nevi

- Medical treatment of vitiligo

- Laser for repigmenting vitiligo

- What’s new in hypochromy

- Use of the 308-nm excimer laser for psoriasis and vitiligo

- Place du laser Excimer à 308 nm dans le traitement du vitiligo

- Physiopathology and genetics of vitiligo

- The 308 nm excimer laser in dermatology

- Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo

- Genetic disorders of pigmentation

- Topical Tacrolimus and the 308-nm Excimer Laser

- Treatment of Vitiligo by 308-nm Excimer Laser

- Treatment of vitiligo by topical calcipotriol